iBio, Inc.
IBIO · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $8 | $8 | $15 | $113 |
| - Cash | $9 | $14 | $4 | $23 |
| + Debt | $4 | $4 | $17 | $26 |
| Enterprise Value | $3 | -$2 | $28 | $116 |
| Revenue | $0 | $0 | $0 | $2 |
| % Growth | 77.8% | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | -$2 |
| % Margin | 100% | 100% | – | -101.2% |
| EBITDA | -$17 | -$14 | -$28 | -$26 |
| % Margin | -4,259.8% | -6,231.6% | – | -1,365.3% |
| Net Income | -$18 | -$25 | -$65 | -$50 |
| % Margin | -4,594.3% | -11,069.8% | – | -2,674.7% |
| EPS Diluted | -1.75 | -6.5 | -23.94 | -58.49 |
| % Growth | 73.1% | 72.8% | 59.1% | – |
| Operating Cash Flow | -$15 | -$19 | -$30 | -$38 |
| Capital Expenditures | -$0 | -$0 | -$6 | -$7 |
| Free Cash Flow | -$15 | -$19 | -$36 | -$45 |